CD274 and Sepsis: A follow-up study of sepsis survivors identified a hyperinflammation/immunosuppression phenotype with a significantly higher 1-year mortality risk, demonstrated by CRP as a marker of ongoing inflammation and additional markers of immunosuppression including soluble PD-L1 [10].